In vitro and in vivo characterization of (+)-3-[11C]cyano-dizocilpine S. SihverW. SihverY. Watanabe Pages: 117 - 131
Effect of 5-fluoroindole-2-carboxylic acid (an antagonist of the NMDA receptor-associated glycine site) on the anticonvulsive activity of conventional antiepileptic drugs R. KamińskiB. PrzywaraS. J. Czuczwar Pages: 133 - 146
Effects of kynurenine metabolites on the electrocorticographic activity in the rat I. YokoiY. NishijimaN. Ogawa Pages: 147 - 160
Tolbutamide blocks postsynaptic but not presynaptic effects of adenosine on hippocampal CA1 neurones H. HosseinzadehT. W. Stone Pages: 161 - 172
Melatonin inhibits oxytocin response to insulin-induced hypoglycemia, but not to angioten sin II in normal men P. ChioderaR. VolpiV. Coiro Pages: 173 - 180
In vivo occupation of dopamine D1, D2 and serotonin2A receptors by novel antipsychotic drug, SM-9018and its metabolite, in rat brain Y. TakahashiI. KusumiT. Koyama Pages: 181 - 191
Involvement of endogenous nitric oxide signalling system in brain muscarinic acetylcholine receptor activation T. BordaA. GenaroG. Cremaschi Pages: 193 - 204
5-Hydroxyindoles compounds and nitric oxide voltammetric detection in the rat brain: changes occurring throughout the sleep-wake cycle R. CespuglioS. BurletH. Faradji-Prevautel Pages: 205 - 215
Retrospective application of a set of clinical diagnostic criteria for the diagnosis of multiple system atrophy I. LitvanV. BoothY. Agid Pages: 217 - 227
Bradykinesia and hypokinesia in Parkinson's disease: what's in a name? J. J. van HiltenA. A. van EerdR. A. C. Roos Pages: 229 - 237
Plasma levels of R- and S-salsolinol are not increased in "de-novo" Parkinsonian patients T. MüllerS. Sällström BaumW. Kuhn Pages: 239 - 246
Sertraline induced parkinsonim. A case report and an in-vivo study of the effect of sertraline on dopamine metabolism A. Di RoccoT. BrannanM. D. Yahr Pages: 247 - 251
BDNF and TrkB expression in intrastriatal ventral mesencephalic grafts in a rat model of Parkinson's disease J. SautterM. SabelM. Kiessling Pages: 253 - 263
Pergolide: treatment of choice in Restless Legs Syndrome (RLS) and Nocturnal Myoclonus Syndrome (NMS). Longterm follow up on pergolide J. StaedtH. HünerjägerG. Stoppe Short Communication Pages: 265 - 268
Neurotransmitter amino acids in cerebrospinal fluid of patients with Alzheimer's disease F. J. Jiménez-JiménezJ. A. MolinaJ. Arenas Pages: 269 - 277
Cerebrospinal fluid levels of non-neurotransmitter amino acids in patients with Alzheimer's disease J. A. MolinaF. J. Jiménez-JiménezR. Enríquez-de-Salamanca Pages: 279 - 286
Abnormal amino acid metabolism in patients with early stage Alzheimer dementia D. FekkesT. J. M. van der CammenL. Pepplinkhuizen Pages: 287 - 294
Antiglutamatergic therapy in Alzheimer's disease – effects of lamotrigine S. TekinC. Aykut-BingölS. Aktan Short Communication Pages: 295 - 303
Abnormal persistence of cerebellar serotonin-1A receptors in schizophrenia suggests failure to regress in neonates P. SlaterC. A. DoyleJ. F. W. Deakin Pages: 305 - 315
Adult treatment with haloperidol increases dentate granule cell proliferation in the gerbil hippocampus R. R. DawirsK. HildebrandtG. Teuchert-Noodt Pages: 317 - 327
Repeated trimipramine induces dopamine D2/D3 and α1-adrenergic up-regulation J. MajZ. RogóżW. Margas Pages: 329 - 342